In the 5th WHO classification of hematopoietic and lymphoid neoplasms, it was classified as “myeloid and lymphoid neoplasms associated with FGFR1 abnormalities (MLN-FGFR1 abnormalities)” in the “myeloid and lymphoid neoplasms with eosinophilia and tyrosine kinase gene fusions (MLN-TK)” [2]. This evidence concerns the gene FGFR1 and lymphoid neoplasm.